Factbox-Elon Musk’s ‘unfathomable’ $56 billion Tesla pay package

(Reuters) – A Delaware judge has tossed out Elon Musk’s record-breaking $56 billion Tesla pay package, calling the compensation granted by the EV maker’s board “an unfathomable sum” that was unfair to shareholders. Following are details about Musk’s pay package. HOW WAS MUSK’S COMPENSATION STRUCTURED? Musk’s 2018 compensation package created 12 tranches of options –…

Read More

Investors punish Microsoft, Alphabet as AI returns fall short of lofty expectations

By Jeffrey Dastin and Samrhitha A (Reuters) -Tech giants on Tuesday talked up how customers are lapping up their generative AI-powered products, but mounting costs of developing the cutting-edge features irked investors hoping for a big boost to sales from the new technology. Shares of Alphabet closed 7.5% lower, while those of Microsoft fell 2.7%,…

Read More

Fed holds rates steady, says more confidence needed in inflation slowdown

NEW YORK (Reuters) -The Federal Reserve left interest rates unchanged on Wednesday but took a major step towards lowering them in coming months in a policy statement that tempered inflation concerns with other risks to the economy and dropped a longstanding reference to possible further hikes in borrowing costs. MARKET REACTION: STOCKS: The S&P 500…

Read More

China, US to cooperate on fentanyl, Beijing hopes for ‘positive energy’

BEIJING (Reuters) -The U.S. and China launched a joint counter-narcotics working group on Tuesday in the first overt sign of cooperation in tackling the spread of fentanyl since late 2019, before bilateral relations between the superpowers soured. It follows a key summit in San Francisco in November where U.S. President Joe Biden and Chinese leader…

Read More

Pfizer posts surprise 4th quarter profit, but key products miss on sales

By Michael Erman and Bhanvi Satija (Reuters) -Pfizer reported a surprise quarterly profit on Tuesday, helped by cost cuts and higher-than-expected demand for its COVID treatment Paxlovid, but sales of some high profile products fell short of Wall Street estimates. Pfizer shares were off around 1% in afternoon trading. Investors fled Pfizer last year as…

Read More